V5 Ultimate
Ultimate
PricingResourcesCompany
Start free trial
HomeGlossaryModified-Release Supplement Tech
Manufacturing

Modified-Release Supplement Tech

Supplement Encapsulation, Coating and Modified-Release Technology · enteric coating · liposomal delivery · microencapsulation · sustained-release · USP <2040>

In short

Technology playbook for enteric coating (Eudragit/HPMCP/HPMCAS/CAP/PVAP at pH thresholds with USP <2040> two-stage dissolution), microencapsulation (spray dry/fluid bed/coacervation), liposomal delivery (verified phospholipid vesicle structure via cryo-EM/DLS, not emulsion mislabelled), sustained-release matrices and the claim-substantiation discipline behind each technology.

Modified-release supplement technology covers the encapsulation, coating and matrix systems used to control where, when and how an active is released in vivo. Enteric coating protects gastric-acid-degraded actives (probiotics, enzymes) and reduces palatability issues (fish oil burp-back), using methacrylic acid copolymers (Eudragit L/S/FS series with defined pH thresholds — L 100 dissolves at pH ≥6.0, L 100-55 at pH ≥5.5, S 100 at pH ≥7.0), hypromellose phthalate, hypromellose acetate succinate, cellulose acetate phthalate or polyvinyl acetate phthalate. USP <2040> Disintegration and Dissolution of Dietary Supplements defines the two-stage test (2 h in 0.1 N HCl acid stage with <10% release, then buffer stage at target pH with >75% release in 45-60 min). Microencapsulation encloses individual active particles at micrometre scale via spray drying, fluid-bed coating, coacervation or emulsion solidification — matrix materials include gum arabic, modified starch, maltodextrin, gelatin, chitosan, alginate, whey protein, lipid systems. Liposomal delivery uses phospholipid vesicles (soy/sunflower/egg lecithin) — the recurring compliance failure is 'liposomal' label claims on products lacking verified phospholipid bilayer vesicle structure (often simple oil-in-water emulsions or micelle systems), exposing brands to FDA Warning Letters and class-action litigation; defensible liposomal claims require characterisation by cryo-electron microscopy and dynamic light scattering with encapsulation efficiency and vesicle-size distribution evidence, with head-to-head PK study evidence for comparative bioavailability claims. Sustained-release matrix systems use hydrophilic polymers (hypromellose, alginate, xanthan, CMC) or hydrophobic matrices (waxes, hydrogenated oils, ethylcellulose) with multi-time-point USP <2040> dissolution validation and discriminating method development. Manufacturing controls include polymer/lipid raw material specification with lot consistency, validated process parameters (coating-bed temperature, spray rate, atomisation, drying, curing), in-process controls (coating weight gain, particle size, granule size), finished-product dissolution and content uniformity per USP <905>, and stability-indicating dissolution across shelf life because modified-release profiles often drift with polymer ageing.

Regulatory anchors
  • USP <2040>
  • USP <905>
  • ICH Q6A
  • 21 CFR 111
Where this term comes up
Dietary SupplementsPharmaceutical
How V5 handles it
QMS — quality records next to the work they concern.
Deviations, corrective actions and quality review sit in the same system as production, so each quality record references the work order, step and lot it concerns.
Lab & QC — results against the limit, reviewed by a second person.
Sample plans, requests, lab queues and results in the same system as production. Reviewed results feed certificates of analysis and the release review; people decide.
Document control — one version in force, every change signed and explained.
Draft the next revision while the current one stays in use, approve it under your sign-off route, and track training on it — with the history kept.
QC release — see what is open, then a person decides.
The review starts from exceptions and open items linked to the lot. Release or hold is recorded and signed by the person responsible, under your procedures.
Related terms
Probiotic CFUContent UniformityClaims Substantiation
Software that covers Modified-Release Supplement Tech
V5 Ultimate (Dietary Supplements)
V5 Ultimate runs Master Manufacturing Records and executed Batch Production Records under 21 CFR Part 111, with mandatory…
V5 Ultimate Dietary Supplements
Written for supplement contract manufacturers and brand owners tired of surviving FDA 483s on paper.
Exploring software for this?

Try V5 free for 7 days with no card needed, or talk to our team about what applies to your operation.

Start free
Back to glossary

Next step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse all features
V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal centre

© V5 Ultimate